This provider's $9.7M in total Medicare payments ranks in the 98th percentile of Ophthalmology providers nationally.
Medicare payments to this provider grew 68% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $255.99 | $182.49 | 1.40x | $73.50 | $806.7K | 8.8K | 3.6K |
| 2015 | $231.54 | $172.15 | 1.34x | $59.39 | $923.0K | 9.3K | 4.1K |
| 2016 | $189.86 | $139.91 | 1.36x | $49.95 | $992.5K | 9.4K | 4.1K |
| 2017 | $187.63 | $140.48 | 1.34x | $47.15 | $747.5K | 8.4K | 3.9K |
| 2018 | $177.65 | $136.23 | 1.30x | $41.42 | $869.9K | 8.0K | 3.6K |
| 2019 | $154.87 | $112.32 | 1.38x | $42.55 | $786.1K | 7.8K | 3.8K |
| 2020 | $328.39 | $150.32 | 2.18x | $178.07 | $835.7K | 7.5K | 3.5K |
| 2021 | $336.90 | $152.61 | 2.21x | $184.29 | $1.1M | 9.4K | 4.1K |
| 2022 | $351.75 | $137.04 | 2.57x | $214.71 | $1.3M | 10.5K | 4.3K |
| 2023 | $354.14 | $134.25 | 2.64x | $219.89 | $1.4M | 12.0K | 4.7K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 3.5K | $2.6M | $730.74 | 1.85x |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 23.1K | $2.2M | $93.82 | 1.97x |
| 67028 | Injection of drug into eye | 12.9K | $1.2M | $92.17 | 2.03x |
| 92235 | Examination of retinal blood vessels by ophthalmoscope | 8.9K | $757.1K | $84.80 | 1.90x |
| 92242 | Imaging of blood vessels in back of eye using fluorescein and indocyanine-green dye | 3.5K | $671.8K | $192.53 | 1.70x |
| 92134 | Diagnostic imaging of retina | 15.2K | $485.5K | $31.86 | 2.09x |
| J9035 | Injection, bevacizumab, 10 mg | 8.1K | $449.4K | $55.60 | 2.29x |
| 92250 | Photography of the retina | 8.4K | $388.4K | $46.24 | 1.77x |
| 92240 | Examination of eye using an endoscope | 1.7K | $327.9K | $194.23 | 1.37x |
| J2778 | Injection, ranibizumab, 0.1 mg | 909 | $252.0K | $277.22 | 1.58x |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | 1.9K | $208.6K | $110.21 | 2.10x |
| 67210 | Laser destruction of retinal growth, 1 or more sessions | 143 | $59.7K | $417.61 | 1.57x |
| 67228 | Laser destruction of leaking retinal blood vessels, 1 or more sessions | 49 | $38.7K | $790.32 | 1.39x |
| 76512 | Ultrasound of eye disease, growth, or structure | 605 | $33.2K | $54.90 | 2.01x |
| 92287 | Imaging and evaluation of deep cells of the eye | 277 | $32.1K | $115.77 | 2.07x |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 114 | $17.7K | $155.56 | 2.48x |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | 240 | $15.7K | $65.32 | 1.81x |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | 221 | $9.3K | $42.29 | 2.77x |
| 92226 | Examination of eye by ophthalmoscope with retinal drawing | 311 | $5.7K | $18.32 | 1.42x |
| 92225 | Examination of eye by ophthalmoscope with retinal drawing | 212 | $4.3K | $20.34 | 1.42x |
This provider submits charges 1.9 times higher than what Medicare actually pays.
A markup ratio of 1.9x means for every $100 Medicare pays, this provider initially charges $190. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Ophthalmology providers in MD for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Michael Elman, M.D. | Baltimore, MD | $68.5M | ✓ Clear |
| David Warrow, M.D. | Hagerstown, MD | $65.5M | ✓ Clear |
| Raymond Sjaarda, M.D. | Baltimore, MD | $47.2M | ✓ Clear |
| Allen Hu, MD | Hagerstown, MD | $45.7M | ✓ Clear |
| James Rial, M.D. | Salisbury, MD | $45.2M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data